← Back to Home

UK commits over £52 million to five health technology hubs to advance early assessment of dementia and infection risks

From integrating brain tests to tracking coughs at home, a new round of UK research funding aims to identify risks earlier and connect people with care. A dementia assessment project will involve more than 1,700 patients, but shorter diagnostic waits and better health outcomes remain goals to be tested.

By SURL BioNews

Can a blood test, a brain scan or a cough recorded on a phone help clinicians determine earlier who needs intervention? UK Research and Innovation (UKRI) announced on November 6 that it would invest more than £52 million in five research and partnership hubs covering dementia, traumatic brain injury, eye imaging, respiratory infections and cardiovascular care. Partners will provide an additional £37.5 million in cash and in-kind support to put new tools to the test in clinics and communities.

Among them, the BRAINIAC project, led by the University of Exeter, will address a challenge in dementia assessment: different tests each offer clues, but clinical practice lacks a reliable way to integrate them. The team plans to use artificial intelligence to combine blood biomarkers, brain imaging, genetic data, electronic health records and digital cognitive assessments, helping healthcare professionals form a more complete assessment of brain health. According to Newcastle University, the project brings together 11 universities and 10 National Health Service (NHS) sites, with £10 million in research funding and a further £10 million in partner support.

The six-year project will work with more than 1,700 patients, aiming to reduce the time needed for assessment and diagnosis by 30% to 50%. The first brain health clinics are expected to begin opening in 2029, initially enrolling patients through NHS referrals. These figures describe the scale of the research, its planned timeline and its performance targets; the announcements so far have not provided diagnostic accuracy data for the integrated tool or demonstrated that it can reduce the risk of developing dementia.

Another approach is to look for clues to systemic diseases in the eyes. The Northern Ophthalmic Research and Innovation hub (NORI), based in Sunderland, will use eye imaging and health data to study how diseases develop over time and explore early signals in routine eye scans that may be associated with diabetes and heart disease. Durham University said the hub would receive £9.1 million from UKRI and an additional £3.1 million from other partners. The Durham team will be responsible for secure computing systems and data analysis to support large-scale health data research.

The CRISP hub, led by the University of Southampton, will focus on acute respiratory infections such as influenza: who can recover at home, and who might become severely ill? Researchers will combine wearable sensors, home testing, smartphone cough analysis and medical records to develop artificial intelligence models that predict the course of illness. The University of Cambridge, the University of Glasgow, the UK Health Security Agency and 21 founding partners will participate, evaluating the entire system in home and community healthcare settings as validation before large-scale clinical deployment.

The other two hubs focus on head impacts and cardiovascular care. BRAIN-SAFE, led by Imperial College London, will build models incorporating age, sex and previous injury history to study how to assess brain injury risk in real time during sports or road accidents. HeartTech, led by King’s College London, will explore using artificial intelligence health coaches to support patients in managing cardiovascular disease at home. Both seek to extend medical assessment to accident scenes or everyday life.

The shared challenge for these investments is whether scattered measurements can be turned into reliable, actionable information. The Southampton team also noted that engineering challenges remain in ensuring measurements are reliable and translating them into care recommendations. Whether earlier warnings lead to better health outcomes, and whether incorrect assessments increase unnecessary tests and referrals, are questions that subsequent clinical evaluations will need to answer. Securing funding gives these ideas an opportunity to be tested, but there is still some way to go before they become part of routine care.

References

  1. UK Research and Innovation
  2. Newcastle University
  3. Durham University
  4. University of Southampton